Showing 1 - 10 of 15
We study the impact of expert reviews on the demand for HIV treatments. A novel feature of our study is that we observe two reviews for each HIV drug and focus attention on consumer responses when experts disagree. Reviews are provided by both a doctor and an activist in the HIV lifestyle...
Persistent link: https://www.econbiz.de/10012914708
Persistent link: https://www.econbiz.de/10011895697
We study the impact of expert reviews on the demand for HIV treatments. A novel feature of our study is that we observe two reviews for each HIV drug and focus attention on consumer responses when experts disagree. Reviews are provided by both a doctor and an activist in the HIV lifestyle...
Persistent link: https://www.econbiz.de/10011709785
We study the impact of expert reviews on the demand for HIV treatments. A novel feature of our study is that we observe two reviews for each HIV drug and focus attention on consumer responses when experts disagree. Reviews are provided by both a doctor and an activist in the HIV lifestyle...
Persistent link: https://www.econbiz.de/10012452901
Persistent link: https://www.econbiz.de/10011793490
Many models from epidemiology are not designed to capture tradeoffs between health and economic well-being and few are equipped to predict how these tradeoffs interact with individuals' preferences to influence behavior. Policies based on such models may not reflect societal preferences or...
Persistent link: https://www.econbiz.de/10012585382
I develop a dynamic framework to assess the value of pharmaceutical innovation, taking explicit account of how side effects and the labor market affect the demand for medical treatment. In the framework, forward-looking patients do not simply maximize underlying health or longevity. Rather, they...
Persistent link: https://www.econbiz.de/10011800727
Persistent link: https://www.econbiz.de/10011863565
Persistent link: https://www.econbiz.de/10011581245
Persistent link: https://www.econbiz.de/10011656542